Balancing the books for cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal metastases in a diminishing economy: a global issue

Authors

  • John Bunni Peritoneal Malignancy Institute, Basingstoke, Hampshire Hospitals Foundation Trust
  • Brendan J. Moran Peritoneal Malignancy Institute, Basingstoke, Hampshire Hospitals Foundation Trust

DOI:

https://doi.org/10.4081/joper.2017.53

Keywords:

Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, Hyperthermic intraperitoneal chemotherapy, colorectal cancer, Colorectal cancer, peritoneal metastases., Peritoneal metastases

Abstract

Medical advances, particularly technological and pharmaceutical, are continually increasing, and this pattern is likely to continue. In contrast to this technological and pharmaceutical expansion, the reality of a global recession and the need to cut costs are universal health-care challenges. Herein the authors review the approximate cost estimates for a proven strategy to manage colorectal peritoneal metastases, namely cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy and different tools government or heath care providers use in deciding which treatments to fund and remunerate.

Downloads

Download data is not yet available.

Downloads

Published

2017-06-21

How to Cite

1.
Bunni J, Moran BJ. Balancing the books for cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal metastases in a diminishing economy: a global issue. J Peritoneum [Internet]. 2017 Jun. 21 [cited 2024 Nov. 23];2(2). Available from: https://joper.pagepress.net/index.php/joper/article/view/53

Issue

Section

Original Articles from PSOGI Congress

Similar Articles

You may also start an advanced similarity search for this article.